Skip to main content
. 2015 May 7;6(5):e1753. doi: 10.1038/cddis.2015.77

Table 2. Thirty-four effective drugs were classified into six different functional groups.

Function Drug name PubMed search
Experiment
    Brain cancer Other cancers MTT IC50 (μM) Clonogenic IC50 (μM)
Anti-inflammation Tanespimycin V V <0.1 ND
  15-delta prostaglandin J2 V V >10 <10
  Luteolin V V <10 <10
  Parthenolide V V 5~10 <10
Antibiotics Thiostrepton V V <1 ND
  Antimycin A V V <1 <10
  Sulconazole N/A N/A >10 <10
  Cycloserine V V <10 ND
Antipsychotics Chlorpromazine V V 5~10 <3.3
  Trifluoperazine V V >10 <1
  Thioridazine V V 5~10 <10
  Prochlorperazine V V >10 <10
  Fluphenazine V V 5~10 ND
  Perphenazine V V 5~10 <10
Cardiovascular drugs Piperlongumine V V <1 ND
  Propafenone N/A V >10 <10
  Phenoxybenzamine V V >10 <10
  Amiodarone V V >5 ND
Chemotherapeutic drugs Daunorubicin V V <1 ND
  Camptothecin V V <0.1 <10
  Thioguanosine V V <5 ND
  8-azaguanine V V <10 ND
  GW-8510 N/A V <3 ND
  Ellipticine V V <1 ND
Others Cloperastine N/A N/A >10 <10
  Nitrarine dihydrochloride N/A N/A >10 <10
  Emetine V V <0.1 ND
  Tyloxapol N/A V 5~10 ND
  Norcyclobenzaprine N/A N/A >10 <10
  Trichostatin A V V <0.33 ND
  Pyrvinium N/A V <0.1 ND
  Bepridil V V 5~10 ND
  Verteporfin N/A V <3.3 ND
  Vorinostat V V <1 ND

Abbreviations: ‘N/A', no evidence linked to cancer in PubMed; ‘ND', not determined